Hepatology 67 , 549559 (2018)
Dumoutier L, Leemans C, Lejeune D, Kotenko SV, Renauld JC
Hashioka, Sadayuki, Youn-Hee Han, Shunsuke Fujii, Takahiro Kato, Akira Monji, Hideo Utsumi, Makoto Sawada, Hiroshi Nakanishi, and Shigenobu Kanba
Published protocols using BPC-157 and TB-500 in combination typically follow a loading phase of daily or every-other-day administration for 2-4 weeks, followed by reduced frequency for maintenance
Closing: The Clinical Bottom Line on Sermorelin Before and After The sermorelin before and after picture is consistent, well-documented, and predictable when the protocol is managed correctly
[1] PFK-1 is inhibited when ATP and/or citrate concentrations increase, that is, when the cells energy charge is high